Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
More about this item
KeywordsPharmaceutical industry; Price discrimination; Ramsey pricing; Antitrust policy; Parallel trade; Regulation; JEL classifications: L41; L51; L65; 111; K21;
- L41 - Industrial Organization - - Antitrust Issues and Policies - - - Monopolization; Horizontal Anticompetitive Practices
- L51 - Industrial Organization - - Regulation and Industrial Policy - - - Economics of Regulation
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
- K21 - Law and Economics - - Regulation and Business Law - - - Antitrust Law
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:ijecbs:v:4:y:1997:i:3:p:301-322. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Chris Longhurst). General contact details of provider: http://www.tandfonline.com/CIJB20 .
We have no references for this item. You can help adding them by using this form .